These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3704172)

  • 21. Apparent tolerance to some aspects of amphetamine stereotypy with long-term treatment.
    Rebec GV; Segal DS
    Pharmacol Biochem Behav; 1980 Dec; 13(6):793-7. PubMed ID: 7193874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of the behavioral effects of amphetamine in rats by clonidine.
    Mueller K; Nyhan WL
    Eur J Pharmacol; 1982 Sep; 83(3-4):339-42. PubMed ID: 6293845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute and chronic behavioral interactions between phencyclidine (PCP) and amphetamine: evidence for a dopaminergic role in some PCP-induced behaviors.
    Greenberg BD; Segal DS
    Pharmacol Biochem Behav; 1985 Jul; 23(1):99-105. PubMed ID: 4041046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of adenosine receptor agonists and antagonists on amphetamine-induced stereotypy in rats.
    Poleszak E; Malec D
    Pol J Pharmacol; 2000; 52(6):423-9. PubMed ID: 11334236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissociation of stereotyped biting responses and oro-bucco-lingual dyskinesias.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1976 Apr; 36(2):423-9. PubMed ID: 945168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of dose, novelty, and exploration on amphetamine-produced stereotyped behavior.
    Russell RL; Pihl RO
    Psychopharmacology (Berl); 1978 Dec; 60(1):93-100. PubMed ID: 104351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coping and the stress-induced potentiation of stimulant stereotypy in the rat.
    MacLennan AJ; Maier SF
    Science; 1983 Mar; 219(4588):1091-3. PubMed ID: 6681679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maintenance of amphetamine-induced stereotypy and locomotion requires ongoing dopamine receptor activation.
    Conti LH; Segal DS; Kuczenski R
    Psychopharmacology (Berl); 1997 Mar; 130(2):183-8. PubMed ID: 9106917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitization of stereotyped behavior to amphetamine is context and response dependent.
    Battisti JJ; Chang CH; Uretsky NJ; Wallace LJ
    Pharmacol Biochem Behav; 1999 Jun; 63(2):263-9. PubMed ID: 10371655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced stereotyped response to amphetamine after pretreatment with small doses of molindone.
    Conway P; Uretsky NJ
    Neuropharmacology; 1983 May; 22(5):579-86. PubMed ID: 6308493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of naloxone and morphine on dopamine agonist-induced stereotypy in rats and guinea pigs.
    Feigenbaum J; Yanai J; Moon B; Klawans H
    Neuropharmacology; 1983 Dec; 22(12A):1369-76. PubMed ID: 6686653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chloroquine potentiation of thioridazine effects in rats and drug-resistant schizophrenic patients: a preliminary report.
    Traficante LJ; Hine B; Gershon S; Sakalis G
    Commun Psychopharmacol; 1977; 1(4):407-19. PubMed ID: 354856
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of the 5-HT3 receptor antagonist ondansetron on amphetamine-induced hyperactivity and stereotypy in rats.
    Shankar RP; Karan RS; Handu SS; Bhargava VK
    Indian J Physiol Pharmacol; 2000 Jul; 44(3):355-8. PubMed ID: 10941627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Responses of neurons in dorsal striatum during amphetamine-induced focused stereotypy.
    Rebec GV; White IM; Puotz JK
    Psychopharmacology (Berl); 1997 Apr; 130(4):343-51. PubMed ID: 9160850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis.
    Sharp T; Zetterström T; Ljungberg T; Ungerstedt U
    Brain Res; 1987 Jan; 401(2):322-30. PubMed ID: 3815099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine.
    Spyraki C; Fibiger HC
    Eur J Pharmacol; 1981 Sep; 74(2-3):195-206. PubMed ID: 7198991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple daily amphetamine administration: behavioral and neurochemical alterations.
    Segal DS; Weinberger SB; Cahill J; McCunney SJ
    Science; 1980 Feb; 207(4433):905-7. PubMed ID: 7188815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-stimulation and locomotor changes indicating "latent" anticholinergic activity by an atypical neuroleptic (thioridazine).
    Herberg LJ; Wishart TB
    Neuropharmacology; 1981 Jan; 20(1):55-60. PubMed ID: 7219681
    [No Abstract]   [Full Text] [Related]  

  • 39. Thioridazine dose effects with reference to stereotypic behavior in mentally retarded residents.
    Aman MG; White AJ
    J Autism Dev Disord; 1988 Sep; 18(3):355-66. PubMed ID: 3170454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerance to amphetamine: contingent suppression of stereotypy mediates recovery of feeding.
    Wolgin DL; Thompson GB; Oslan IA
    Behav Neurosci; 1987 Apr; 101(2):264-71. PubMed ID: 3580129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.